Risk factors for pneumonitis in patients treated with anti‐programmed death‐1 therapy: A case‐control study

Abstract Immune checkpoint blockade‐related pneumonitis is a rare but potentially life‐threatening adverse effect, but its risk factors are not completely understood. This case‐control study was conducted to identify pneumonitis risk factors in patients treated with anti‐PD1 monoclonal antibodies (m...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Pengfei Cui, Zhefeng Liu, Guoqiang Wang, Junxun Ma, Yuanyu Qian, Fan Zhang, Chun Han, Yaping Long, Ye Li, Xuan Zheng, Danyang Sun, Jing Zhang, Shangli Cai, Shunchang Jiao, Yi Hu
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Wiley 2018-08-01
סדרה:	Cancer Medicine
נושאים:	anti‐PD‐1 case‐control study pneumonitis risk factors
גישה מקוונת:	https://doi.org/10.1002/cam4.1579
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!